Burn: An inflammatory process;La brûlure: une pathologie inflammatoire

Pathologie Biologie

Volumn 59, Issue 3, 2011, Pages

  Ravat, F ^a   Payre, J ^a   Peslages, P ^a   Fontaine, M ^a   Sens, N ^a  

^a CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

Author keywords

Burn; Cytokines; Immune dysfunction; Immunity; Inflammation; Inflammatory; Lymphocyte; Macrophage; Thermal injury

Indexed keywords

CYTOKINE; AUTACOID; BIOLOGICAL MARKER; FREE RADICAL; IRON;

ARTICLE; BURN; CARDIOVASCULAR FUNCTION; CELLULAR IMMUNITY; ENDOTHELIUM; HUMAN; INFLAMMATION; MACROPHAGE; MEMBRANE PERMEABILITY; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN INTERACTION; SKIN INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERMAL INJURY; BIOLOGICAL MODEL; CAPILLARY PERMEABILITY; DEBRIDEMENT; HEMODYNAMICS; HEMOFILTRATION; IMMUNOLOGY; INFECTION; METABOLISM; PHYSIOLOGY; REVIEW; SKIN TRANSPLANTATION; T LYMPHOCYTE; THROMBOPHILIA;

BIOLOGICAL MARKERS; BURNS; CAPILLARY PERMEABILITY; CYTOKINES; DEBRIDEMENT; FREE RADICALS; HEMODYNAMICS; HEMOFILTRATION; HUMANS; IMMUNITY, CELLULAR; INFECTION; INFLAMMATION MEDIATORS; IRON; MACROPHAGES; MODELS, BIOLOGICAL; PROGNOSIS; SKIN TRANSPLANTATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES; THROMBOPHILIA;

EID: 79958718336     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.12.001     Document Type: Article

References (105)

1. Sherwood E.R., Traber D.L. The systemic inflammatory response syndrome. Total burn care 2007, 293-309. Saunders-Elsevier. 3rd edn. D.H. Herndon (Ed.).
2. Robbins pathologic basis of disease 1999, 75. WB Saunders, Philadelphia. 6th edn. R. Cotran, V. Kumar, T. Collins (Eds.).
3. Schwacha M.G. Macrophages and post-burn immune dysfunction. Rev Burns 2003, 29:1-14.
4. Jeschke M.G., Mlcak R.P., Finnerty C.C., Norbury W.B., Gauglitz G.G., Kulp G.A., et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care Med 2007, 35(Suppl.):S519-S523.
5. Gosain A., Gamelli R.D. A primer in cytokines. J Burn Care Res 2005, 26:7-12.
6. Deitch E.A. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992, 216:117-134.
7. Spooner C.E., Markowitz N.P., Saravolatz L.D. The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 1992, 62:S11-S17.
8. Voss M., Cotton M.F. Mechanisms and clinical implications of apoptosis. Hosp Med 1998, 59:924-930.
9. Wanek S., Wolf S.E. Metabolic response to injury and role of anabolic hormones. Curr Opin Clin Nutr Metab Care 2007, 10:272-277.
10. Van der poll T., Van deventer S.J. Cytokines and anticytokines in the pathogenesis of sepsis. Inf Dis Clin North Am 1999, 13:413-426.
11. Laffon M., Pittet J.F., Modelska K., Matthay M.A., Young D.M. Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barrier in rabbits. Am J Respir Crit Care Med 1999, 160:1443-1449.
12. Czermak B.J., Sarma V., Pierson C.L., Warner R.L., Huber-Lang M., Bless N.M., et al. Protective effects of C5a blockade in sepsis. Nat Med 1999, 5:788-792.
13. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
14. Christman J.W., Lancaster L.H., Blackwell T.S. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 1998, 24:1131-1138.
15. Bohrer H., Qiu F., Zimmermann T., Zhang Y., Jllmer T., Männel D., et al. Role of NKkappaB in the mortality of sepsis. J Clin Invest 1997, 100:972-985.
16. Schwartz M.D., Moore E.E., Moore F.A., Shenkar R., Moine P., Haenel J.B., et al. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996, 24:1285-1292.
17. Carlson D.L., Horton J.W. Cardiac molecular signalling after burn trauma (summary article). J Burn Care Res 2006, 27:669-675.
18. Parihar A., Parihar M.S., Milner S., Bhat S. Oxidative stress and antoixydative mobilisation in burn injury. Burns 2008, 34:6-17.
19. Guemouri L., Artur Y., Herbeth B., Jeandel C., Ceny G., Siest G. Biological variability of superoxyde dismutase, glutathione peroxydase, and catalase in blood. Clin Chem 1991, 37:1932-1937.
20. Brunnee T., La Porta C., Reddigari S.R., Salerno V.M., Kaplan A.P., Silverberg M. Activation of factor XI in plasma is dependent on factor XII. Blood 1993, 81:580-586.
21. Pawlinski R., Pedersen B., Kehrle B., Aird W.C., Frank R.D., Guha M., et al. Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood 2003, 101:3940-3947.
22. Messori A., Vacca F., Vaiani M., Trippoli S Antithrombin III in patients admitted to intensive care units: a multicenter observational study. Crit Care 2002, 6:447-451. Gruppo di Studio sull'antitrombina III.
23. Okajima K. regulation of inflammatory responses by natural anticoagulants. Immunol Rev 2001, 184:258-274.
24. Yuksel M., Okajima K., Uchiba M., Horiuchi S., Okabe H. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B andactivator protein-1 in human monocytes. Thromb Haemost 2002, 88:267-273.
25. Broze G.I. The rediscovery and isolation of TFPI. J Thromb Haemost 2003, 1:1671-1675.
26. Clemenza L., Dieli F., Cicardi M., Salerno A. Research on complement: old issues revisited and a novel sphere of influence. Trends Immunol 2003, 24:292-296.
27. Sugi K., Newald J., Traber L.D., Maguire J.P., Herndon D.N., Schlag G., et al. Cardiac dysfunction after acute endotoxine administration in conscious sheep. Am J Physiol 1991, 260:H1474-H1481.
28. Noshima S., Noda H., Herndon D.N., Traber L.D., Traber D.L. Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep. J Appl Physiol 1993, 74:1528-1533.
29. Godsoe A., Kimura R., Herndon D.N., Flynn J.T., Schlag G., Traber L., et al. Cardiopulmonary changes with intermittent endotoxine administration in sheep. Circ Shock 1988, 25:61-74.
30. Meyer J., Traber L.D., Nelson S., Lentz C.W., Nakazawa H., Herndon D.N., et al. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 1992, 73:324-328.
31. Fujioka K., Sugi K., Isago T., Flynn J.T., Traber L.D., Herndon D.N., et al. Thromboxane synthase inhibition and cardiopulmonary function during endotoxemia in sheep. J Appl Physiol 1991, 71:1376-1381.
32. Adams J., Traber D.L. The effects of a prostaglandin synthetase inhibitor, ibuprofen, on the cardiopulmonary response to endotoxin in sheep. Circ Shock 1982, 9:481-489.
33. Navaratnam R.L., Morris S.E., Traber D.L., Flynn J., Woodson L., Linares H., et al. Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT). J Trauma 1990, 30:1104-1113.
34. Lefer A.M. Interaction between myocardial depressant facto rand vasoactive mediators with ischemia and shock. Am J Physiol 1987, 252:R193-R205.
35. Morris S.E., navaratnam N., Herndon D.N. A comparison of effects of thermal injury and smoke inhalation on bacterial translocation. J Trauma 1990, 30:639-643.
36. Koltai M., Hosford D., Braquet P.G. Platelet-activating factor in septic shock. New Horizons 1993, 1:87-95.
37. Theissen J.L., Loick H.M., Curry B.B., Traber L.D., Herndon D.N., Traber D.L. Time course of hypoxic pulmonary vasoconstriction after endotoxin administration in unanesthetized sheep. J Appl Physiol 1991, 70:2120-2125.
38. Meyer J., Lentz C.W., Stothert J.C., Traber L.D., Herndon D.N., Traber D.L. Effects of nitric oxyde synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 1994, 22:306-312.
39. Martin W., White D.G., henderson A.H. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol 1988, 93:229-239.
40. Cherner J.A., Singh G., Naik L. atrial natriuretic factor activates membrane-bound guanylate cyclase of chief cells. Life Sci 1990, 47:669-677.
41. Goy M.F. Activation of membrane guanylate cyclase by an invertebrate peptide hormone. J Biol Chem 1990, 265:20220-20227.
42. Horton J.W. Left ventricular contractile dysfunction as a complication of thermal injury. Shock 2004, 22:495-507.
43. Horton J.W., Garcia N.M., White D.J., Keffer J. Postburn cardiac contractile function and biochemical markers of postburn cardiac injury. J Am Coll Surg 1995, 181:289-298.
44. Brigham K.L., Bowers R., Haynes J. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res 1979, 45:292-297.
45. Lund T., Wiig H., Reed R.K., Aukland K. A " new" mechanism for oedema generation: strongly negative interstitial fluid pressure causes rapid fluid flow into thermally injured skin. Acta physiol Scand 1987, 129:433-435.
46. Lund T., Wiig H., Reed R.K. Acute postburn oedema: role of strongly negative interstitial fluid pressure. Am J Physiol 1988, 255:H1069-H1074.
47. Traber D.L., Herndon D.N., Fujioka K., et al. Permeability changes during experimental endotoxemia and sepsis. Shock, sepsis and organ failure: Second Wiggers bernard conference 1991, 425-447. Springer Verlag, New York. G. Schlag, H. Redl, J.H. Siegel (Eds.).
48. Smith L., Andreasson S., Thoren Tolling K., Rippe B., Risberg B. Sepsis in sheep reduces pulmonary microvascular sieving capacity. J Appl Physiol 1987, 62:1422-1429.
49. Oliver J.A. Endothelium-derived relaxing factor contributes to the regulation of endothelium permeability. J Cell Physiol 1992, 151:506-511.
50. Leeuwenberg F.M., Jeunhomme T.M.A., Buurman Wa. Induction of an activation antigen on human endothelial cells in vitro. Eur J Immunol 1989, 19:715-720.
51. Lasky L.A. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992, 258:964-969.
52. Nawroth P.P., Stern D.M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986, 163:740-745.
53. Traber D.A. Anti-proteases in endotoxemia. Prog Clin Biol Res 1987, 236:149-157.
54. Seekamp A., Lalonde C., Zhu D.G., Demling R. Catalase prevents prostanoid release and lung lipid peroxydation after endotoxemia in sheep. J Appl Physiol 1988, 65:1210-1216.
55. Traber D.L., Schlag G., Redl H., Strohmair W., Traber L.D. Pulmonary microvascular changes during hyperdynamic sepsis in an ovine model. Circ Shock 1987, 22:185-193.
56. O'Dwyer S.T., Michie H.R., Ziegler T.R., Revhaug A., Smith R.J., Wilmore D.W. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988, 123:1459-1464.
57. Tokyay R., Loick H.M., Traber D.L., Heggers J.P., Herndon D.N. Effects of thromboxane synthetase inhibition on postburn mesenteric vascular resistance and the rate of bacterial translocation in a chronic porcine model. Surg Gynecol Obstet 1992, 174:125-132.
58. Andrews N. Disorders of iron metabolism (review article). N Engl J Med 1999, 341:1986-1995.
59. Weiss G., Goodnough L.T. Anemia of chronic disease (review article). N Engl J Med 2005, 352:1011-1023.
60. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993, 90:770-774.
61. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 1987, 84:5788-5792.
62. Nishimura T., Nishiura T., De Serres S., Nakagawa T., Meyer A.A. Transforming growth factor-beta 1 and splenocyte apoptotic cell death and burn injuries. J Burn Care Rehabil 2000, 21:128-134.
63. Meert K.L., Ofenstein J.P., Genyea C., Sarnaik A.P., Kaplan J. Elevated Transforming growth factor-beta concentrations correlates with post-trauma immunosuppression. J Trauma 1996, 40:901-906.
64. Varedi M., Jeschke M.G., Englander E.W., Herndon D.N., Barrow R.E. Serum TGF-beta in thermally injured rats. Shock 2001, 16:380-382.
65. Schwacha M.G., Somers S.D. Therma injury induced immunosuppression in mice: the role of macrophage derived reactive nitrogen intermediates. J Leukoc Biol 1998, 63:51-58.
66. Moss N.M., Gough D.B., Jordan A.L., Grbic J.T., Wood J.J., Rodrick M.L., et al. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery 1988, 104:882-887.
67. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350.
68. Salvemini D., Seibert K., Masferrer J.L., Settle S.L., Misko T.P., Currie M.G., et al. Nitric oxide and the cyclooxygenase pathway. Adv Prostaglandin Thomboxane Leukoc Res 1995, 23:491-493.
69. Szabo C. The pathopysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury. Shock 1996, 6:79-88.
70. Liew F.Y. Regulation of lymphocyte functions by nitric oxyde. Curr Opin Immunol 1995, 7:396-399.
71. Masson I., Mathieu J., Nolland X.B., De Sousa M., Chanaud B., Strzalko S., et al. Role of nitric oxide in depressed lymphoproliferative responses and altered cytokine production following thermal injury in rats. Cell Immunol 1998, 186:121-132.
72. Kulkarni S.K., Jain N.K., Singh A. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors. Methods Find Exp Clin Pharmacol 2000, 22:291-298.
73. Bomalaski J.S., Williamson P.K., Zurier R.B. Prostaglandins and the inflammatory response. Clin Lab Med 1983, 3:695-717.
74. Skeen M.J., Ziegler H.K. Intracellular interactions and cytokien responsiveness of peritoneal α/β and γ/δ T cells from Listeria-infected mice: synergistic effects of interleukin 1 and 7 on γ/δ T cells. J Exp Med 1993, 178:985-996.
75. Haas W., Pereira P., Tonegawa S. Gamma/delta cells. Annu Rev Immunol 1993, 11:637-685.
76. Schwacha M.G., Ayala A., Chaudry I.H. Insights into the role of γ/δ T-lymphocytes in the immunopathogenic response to thermal injury. J Leukoc Biol 2000, 67:644-650.
77. Ferrick D.A., Schrenzel M.D., Mulvania T., Hsieh B., Ferlin W.G., Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th-1 and Th-2 stimulating pathogens by γ/δ T cells in vivo. Nature 1995, 373:255-257.
78. Kobayashi M., Herndon D.N., Pollard R.B., Suzuki F. CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV. J Leukoc Biol 1995, 58:159-167.
79. Anderson B.O., Harken A.H. Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 1990, 30:S44-S49.
80. Dehring D.H., Lübbesmeyer H.J., Fader R.C., Traber L.D., Traber D.L. Exaggerated cardiopulmonary response after bacteriemia in sheep with week-old thermal injury. Crit Care Med 1993, 21:888-893.
81. Koike K., Moore F.A., Moore E.E., Poggetti R.S., Tuder R.M., Banerjee A. Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 1992, 52:656-662.
82. Thomas S.J., Morimoto K., Herndon D.N., Ferrando A.A., Wolfe R.R., Klein G.L., et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002, 132:341-347.
83. Pham T.N., Warren A.J., Phan H.H., Molitor F., Greenhalgh D.G., Palmieri T.L. Impact of tight glycemic control in severely burned children. J Trauma 2005, 59:1148-1154.
84. Jeschke M.G., Boehning D.F., Finnerty C.C., Herndon D.N. Effect of insulin on the inflammatory and acute phase response after brun injury. Crit Care Med 2007, 34:S519-S523.
85. Wang C.Z., Barrow R.E., Cox C.S., Yang S.F., Herndon D.N. Influence of detergent aerosol on lung microvascular permeability. J Appl Physiol 1993, 74:1016-1023.
86. Cannon J.G., friedberg J.S., Gelfand J.A., Tompkins R.G., Burke J.F., Dinarello C.A. Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans. Crit Care Med 1992, 20:1414-1419.
87. Zhang B., Huang Y.H., Chen Y., Yang Y., Hao Z.L., Xie S.L. Plasma tumor necrosis factor-alpha, its soluble receptor and interleukin-1 beta levels in critically burned patients. Burns 1998, 24:599-603.
88. Carsin H., Assicot M., Feger F., Roy O., Pennacino I., Le Bever H., et al. Evolution and significance of circulating procalcitonin levels compared with IL-6 TNF-α and endotoxin levels early after thermal injury. Burns 1997, 23:218-224.
89. Drost A.C., Burleson D.G., Ciofi W.G., Jordan B.S., Mason A.D., Pruitt B.A. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 1993, 35:335-339.
90. Sachse C., Machens H.G., Felmerer G., Berger A., Henkel E. Procalcitonin as a marker fort he early diagnosis of severe infection after thermal injury. J Burn Care Rehabil 1999, 20:354-360.
91. Bargues L., Chancerelle Y., Catineau J., Jault P., Carsin H. Evaluation of serum procalcitonin concentation in the ICU following severe burn. Burns 2007, 33:860-864.
92. Carballal S., RadiR, kirk M.C., Barnes S., Freeman B.A., Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 2003, 42:9906-9914.
93. Bar-Or D., Rael L.T., Lau E.P., Rao N.K., Thomas G.W., Winkler J.V., et al. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem Biophys Res Commun 2001, 284:856-862.
94. Kragh-Hanser U., Chuang V.T., Otagiri M. Practical aspects of the ligand-binding enzymatic properties of human serum albumin. Biochem Pharmacol Bull 2002, 25:695-704.
95. Lang J.D., Figueroa M., Chumley P., Aslan M., hurt J., Tarpey M.M., et al. Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology 2004, 100:51-58.
96. Powers K.A., Kapus A., Khadaroo R.G., He R., Marshall J.C., Lindasy T.F., et al. Twenty-five percent albumin prevents lung injury following shock/ressuscitatin. Crit Care Med 2003, 31:2355-2363.
97. Walley K.R., Mc Donald T.E., Wang Y., Dai S., Russel J.A. Albumin ressuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia. Crit Care Med 2003, 31:187-194.
98. Quinlan G.J., Margarson M.P., Mumby S., Evans T.W., Gutteridge J.M. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998, 95:459-465.
99. Sander A., Armbruster W., Sander B., Daul A.E., Lange R., Peters J. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF-alpha plasma concentrations. Intensive Care Med 1997, 23:878-884.
100. Kellum J.A., Johnson J.P., Kramer D., Palevsky P., Brady J.J., Pinsky M.R. Diffusive vs. Convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26:1995-2000.
101. Tompkins R.G., Remensnyder J.P., Burke J.F., Tompkins D.F., Hilton J.F., Schoenfeld D.A., et al. Significant reduction in mortality for children with burn injury through the use of prompt eschar excision. Ann Sur 1988, 208:577-585.
102. Wolf S.E., Rose J.K., Desai M.H., Mileski J.P., Barrow R.E., Herndon D.N. Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80 % TBSA burns (> or = 70 % full-thickness). Ann Surg 1997, 225:554-565.
103. Ho W.S., Ying S.Y., Chan H.H. A study of burn injuries in the elderly in a regional burn center. Burns 2001, 27:382-385.
104. Cetinkale O., Ulualp K.M., Ayan F., Duren M., Cizmeci O., Pusane A. Early wound excision and skin grafting restores cellular immunity after severe burn trauma. Br J Surg 1993, 80:1296-1298.
105. Hultman C.S., Cairns B.A., Deserres S., Frelinger J.A., Meyer A.A. Early, complete burn wound excision partially restores cytotoxic T lymphocyte function. Surgery 1995, 118:421-429.